Physician profile
Mitchell A Pfeiffer
NPI 1366437634
$1,995.77
in general payments reported to CMS, 2019-2025
19 companies · $221 in 2025
The $221 reported for 2025 was more than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $799 · 2020: $47.95 · 2021: $367 · 2022: $207 · 2023: $236 · 2024: $118 · 2025: $221.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $575.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $574.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $752.24 | 2019-2025 | Nucala |
| Pulmonx Corporation | $228.14 | 2019-2025 | Chartis Catheter, Zephyr Endobronchial Valve, Pulmonx Chartis Tablet Console |
| Astrazeneca Pharmaceuticals LP | $197.77 | 2019-2022 | |
| Edwards Lifesciences Corporation | $148.16 | 2021 | |
| Angiodynamics, INC. | $121.34 | 2021 | |
| Ekos Corporation | $110.91 | 2019 | |
| Genentech USA, INC. | $100.82 | 2019-2020 | |
| Mylan Specialty L.P. | $47.06 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $45.98 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $38.06 | 2019 | |
| Grifols USA, LLC | $34.87 | 2019 | |
| Merck Sharp & Dohme LLC | $31.95 | 2019 | |
| Circassia INC. | $31.09 | 2019 | |
| Genzyme Corporation | $24.76 | 2019 | |
| Janssen Pharmaceuticals, INC | $24.30 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $20.99 | 2019 | |
| Novartis Pharmaceuticals Corporation | $13.03 | 2019 | |
| Philips North America LLC | $12.70 | 2019 | |
| Pfizer INC. | $11.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitchell Pfeiffer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.